[Lung cancer: centralisation of multidisciplinary treatment]

The treatment of Pancoast tumours has been a combined-modality effort for several decades. In a recent Dutch publication, the results in 36 patients are described with a mean follow-up of 26 months. These are in line with internationally-achieved outcomes: the overall and disease-free survival after 2 years was 45 and 31%, respectively, and after 5 years 28 and 19%. As such, the approach to superior-sulcus tumours is a very good example of how the modern treatment of lung cancer has developed, and it underlines the need for close collaboration between specialists with different backgrounds. The patients will benefit from centralisation of the treatment in a limited number of institutions in the Netherlands.